Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Early Phase 1
1(50.0%)
N/A
1(50.0%)
2Total
Early Phase 1(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02902614Not ApplicableCompleted

Side of Embryo Biopsy Interfering Implantation Potential

Role: lead

NCT02358759Early Phase 1Completed

Management of Abnormally Fertilized Zygotes? InVitro Correction of 3PN

Role: lead

NCT02329704Completed

Evaluation Study Between Density Gradient and Swimming Down for Semen Processing

Role: lead

NCT02328534Completed

Semen Processing for ICSI Using Swim-down and Density Gradient Methods

Role: lead

All 4 trials loaded